{
    "slug":  "crispr-gene-therapy-breakthrough",
    "category":  "Research",
    "title":  "CRISPR Gene Therapy Cures Sickle Cell Disease in 100 Patients",
    "introText":  "CRISPR gene therapy has cured sickle cell disease in all 100 patients treated in an expanded trial. The one-time treatment permanently corrects the genetic defect, eliminating the need for lifelong blood transfusions.",
    "readingTime":  "7 Min Read",
    "author":  {
                   "image":  "/images/authors/author-1.webp",
                   "name":  "Sarah Mitchell",
                   "role":  "Chief Political Correspondent"
               },
    "lastUpdated":  "December 17, 2025",
    "content":  [
                    {
                        "type":  "image",
                        "content":  "CRISPR cures sickle cell",
                        "imageUrl":  "/images/news/medical-research.webp",
                        "imageAlt":  "Medical research"
                    },
                    {
                        "type":  "heading",
                        "content":  "100% Success Rate",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "All 100 patients in the expanded trial have been cured of sickle cell disease with no disease recurrence after up to four years of follow-up. Patients report dramatic improvements in quality of life."
                    },
                    {
                        "type":  "heading",
                        "content":  "Treatment Process",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Stem cells are removed from patients, edited using CRISPR to correct the sickle cell mutation, then returned. The corrected cells proliferate, producing healthy hemoglobin."
                    },
                    {
                        "type":  "heading",
                        "content":  "Global Impact",
                        "level":  2
                    },
                    {
                        "type":  "paragraph",
                        "content":  "Sickle cell affects millions worldwide, primarily in Africa and among African diaspora populations. The challenge now is making the expensive treatment accessible globally."
                    }
                ],
    "bookmarked":  false
}
